PExA AB is a Sweden-based company engaged in the advanced equipment and technology industry. The Company develops, manufactures and markets a non-invasive research instrument to study respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD). The instrument provides lung researchers with a non-invasive method for collecting microscopic particles, potential biomarkers for diseases, from small airways in exhaled air to diagnose, monitor and provide treatment of respiratory diseases.

Employees

Sector

Advanced Medical Equipment & Technology

More about the company

Quotes

Date	Price	Change
05/10/26	€0.0224	0.00%
02/10/26	€0.0224	-6.67%
01/10/26	€0.0240	+11.11%
30/09/26	€0.0216	0.00%
29/09/26	€0.0216	-0.92%

Delayed Quote Deutsche Boerse AG

More quotes

Delayed Deutsche Boerse AG 16:25:01 05/10/2026 +03			5-day change	1st Jan Change
0.0224 ^EUR	0.00%		+2.75%	+49.33%

09-29	Pexa saw strong interest at the ERS lung congress	FW
09-03	Pexa technology featured in three research presentations at pulmonary congress	FW

Market Cap	27.06M 2.69M 2.4M 2.24M 2.04M 3.84M 260M 3.87M 10.53M 132M 10.12M 9.9M 426M	P/E 2023	-2.18x	P/E 2024	-1.13x
Enterprise Value	21.47M 2.14M 1.91M 1.78M 1.62M 3.04M 206M 3.07M 8.35M 105M 8.02M 7.85M 338M	EV / Sales 2023	3.92x	EV / Sales 2024	8.49x
Free-Float	-	Yield 2023 *	-	Yield 2024	-

Markets		Quality
SPOTLIGHT STOCK MARKET AB	PEXA B	End-of-day quote
Deutsche Boerse AG	FA0	Delayed

09-29	Pexa saw strong interest at the ERS lung congress	FW
09-03	Pexa technology featured in three research presentations at pulmonary congress	FW
08-28	Pexa reports modest performance shifts, CEO: new capital provides substantially greater flexibility	FW
08-28	PExA AB Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
08-20	Pexa's directed share issue registered after positive decision from ISP	FW
08-19	Pexa technology draws attention after silicosis study in Australia	FW
07-28	Pexa's rights issue was oversubscribed	FW
07-13	Pexa - Interview with CEO Tomas Gustafsson	FW
07-10	Pexa raises SEK10m in a directed share issue, Anders Hallberg becomes a major shareholder	FW
07-01	Pexa raises nearly 10 million kronor in fully guaranteed rights issue	FW
06-23	Pexa signs a SEK 7.5m contract with a global pharmaceutical company	FW
06-10	Pexa secures order from the US	FW
06-02	Doctoral thesis presents findings from studies using Pexa technology	FW

PExA AB Stock Deutsche Boerse AG

Stocks

FA0

SE0007412374

Advanced Medical Equipment & Technology

Valuation: PExA AB

Chart: PExA AB

Latest news: PExA AB

Analysts' recommendations: PExA AB

Press Releases: PExA AB

Quotes and Performance

Price Extremes

Managers and Directors: PExA AB

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

11-07	Pexa - Q3 Presentation 2025	FW
11-07	Pexa Reports Minor Earnings Changes as Company Advances Toward Diagnostic Applications	FW

09-03	PExA : at the world’s largest respiratory congress – three accepted abstracts featuring PExA to be presented	PU
06-23	PExA : signs agreement with global pharmaceutical company for 10 instruments for clinical multicenter study in pulmonary fibrosis, with a value of approximately SEK 7.5 million	PU
06-10	PExA : U.S. government agency customer orders upgrade of existing PExA system	PU
06-02	PExA : New doctoral thesis strengthens PExA’s opportunities in lung cancer and other lung diseases	PU
05-13	PExA : partner in Dutch precision medicine project within COPD and interstitial lung diseases	PU

1 week	+2.75%
Current month	+3.70%
1 month	-8.20%
3 months	-16.42%
6 months	+72.31%
Current year	+49.33%

1 week	0.02	0.02
1 month	0.02	0.03
Current year	0.01	0.1
1 year	0.01	0.1
3 years	0.01	0.1
5 years	0.01	0.1
10 years	0.01	0.1

Manager	Title	Age	Since
Bengt Tomas Jan Gustafsson CEO	Chief Executive Officer	55	-
Jörgen Östling CTO	Chief Tech/Sci/R&D Officer	-	01/01/2018
Svante Höjer CTO	Chief Tech/Sci/R&D Officer	65	01/01/2015

Director	Title	Age	Since
Anna-Carin Olin BRD	Director/Board Member	66	01/01/2010
Claes Frederik Holmberg CHM	Chairman	72	31/01/2014
Björn Lennart Dahlöf BRD	Director/Board Member	73	01/01/2021

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
PEXA AB	0.00%	+2.75%	-	-	3.89M
THERMO FISHER SCIENTIFIC, INC.	+3.35%	-0.27%	+24.56%	+35.89%	250B
DANAHER CORPORATION	+3.34%	-2.69%	+2.89%	+2.00%	156B
INTUITIVE SURGICAL, INC.	+3.71%	-2.00%	-10.14%	+40.12%	144B
BOSTON SCIENTIFIC CORPORATION	-0.47%	-3.88%	-56.43%	-17.96%	61.45B
EDWARDS LIFESCIENCES CORPORATION	+2.44%	+0.46%	+13.18%	+20.82%	50.28B
SIEMENS HEALTHINEERS AG	-1.08%	-3.15%	-21.39%	-21.55%	46.73B
AGILENT TECHNOLOGIES, INC.	+2.09%	-2.24%	+20.93%	+55.22%	48.29B
VEEVA SYSTEMS INC.	+3.70%	+1.25%	-4.33%	+40.74%	45.89B
WATERS CORPORATION	+3.51%	-0.64%	+34.02%	+65.46%	43.24B
Average	+2.17%	-2.32%	+0.37%	+24.53%	93.91B
Weighted average by Cap.	+2.85%	-2.77%	+4.28%	+25.27%

	2023	2024
Net sales	2.02M 201K 179K 167K 152K 286K 19.33M 288K 784K 9.86M 753K 737K 31.7M	720K 71.66K 63.92K 59.56K 54.2K 102K 6.9M 103K 280K 3.52M 269K 263K 11.32M
Net income	-8.04M -801K -715K -666K -606K -1.14M -77.14M -1.15M -3.13M -39.37M -3.01M -2.94M -127M	-10.16M -1.01M -903K -841K -765K -1.44M -97.46M -1.45M -3.95M -49.74M -3.8M -3.72M -160M
Net Debt	-9.6M -956K -853K -794K -723K -1.36M -92.06M -1.37M -3.73M -46.99M -3.59M -3.51M -151M	-5.59M -557K -497K -463K -421K -793K -53.64M -799K -2.18M -27.38M -2.09M -2.05M -88M